| Total Voting Rights | 02-Feb-2012 | 07:00 | RNS |
| Holding(s) in Company | 05-Jan-2012 | 10:49 | RNS |
| Blocklisting Six Monthly Return | 29-Dec-2011 | 07:00 | RNS |
| CANCER THERAPY COLLABORATION WITH ASTRAZENECA | 21-Dec-2011 | 07:00 | RNS |
| Chi-Med Loan Facility | 12-Dec-2011 | 07:00 | RNS |
| Initiates Epitinib Phase I clinical study | 04-Nov-2011 | 07:00 | RNS |
| Holding(s) in Company | 05-Sep-2011 | 07:00 | RNS |
| Interim Results | 01-Aug-2011 | 07:00 | RNS |
| China Healthcare Division expansion | 22-Jul-2011 | 07:00 | RNS |
| Notice of Results | 05-Jul-2011 | 07:00 | RNS |
| Blocklisting Interim Review | 29-Jun-2011 | 07:00 | RNS |
| Holding(s) in Company | 13-May-2011 | 08:25 | RNS |
| Result of AGM | 09-May-2011 | 13:18 | RNS |
| Holding(s) in Company | 09-May-2011 | 07:00 | RNS |
| 2010 Annual Report and Notice of AGM | 04-Apr-2011 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 415.00p |
| Change Today | -7.50p |
| % Change | -1.78 % |
| 52 Week High | 535.00 |
| 52 Week Low | 263.00 |
| Volume | 87,877 |
| Shares Issued | 51.74m |
| Market Cap | £214.73m |
| Beta | 0.28 |
| RiskGrade | 250 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 15:56 | 40,000 @ 415.00p |
| 15:56 | 40,000 @ 415.00p |
| 15:33 | 356 @ 410.00p |
| 15:06 | 562 @ 410.00p |
| 14:48 | 356 @ 410.00p |
You are here: research